XML 95 R20.htm IDEA: XBRL DOCUMENT v3.20.1
Stock Option Plans
12 Months Ended
Dec. 31, 2019
Stock Option Plans  
Stock Option Plans

Note 12. Stock Option Plans

Delmar Bancorp Stock Option Plan

The Company had employee and director stock option plans and had reserved shares of stock for issuance thereunder. Options granted under these plans had a ten‑year life with a four‑year vesting period that began one year after date of grant, and were exercisable at a price equal to the fair value of the Company's stock on the date of the grant. Each award from all plans was evidenced by an award agreement that specified the option price, the duration of the option, the number of shares to which the option pertains, and such other provisions as the grantor determines. The plan term ended in 2014, therefore no new options can be granted.  During 2018 5,000 stock options were exercised from the Delmar Bancorp stock option plan at an exercise price of $1.98.  No stock options were exercised during 2019.  All remaining options expired during 2019.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employees

 

Directors

 

 

 

 

Average

 

 

 

 

 

 

Average

 

 

 

 

    

Shares

    

Price

    

Amount

    

Shares

    

Price

    

Amount

December 31, 2019

 

13,895

 

$

9.05

 

$

125,750

 

4,514

 

$

9.05

 

$

40,852

 

Liberty Bell Stock Option Plan

In 2004 Liberty Bell Bank adopted the 2004 Incentive Stock Option Plan and the 2004 Non‑Qualified Stock Option Plan, which were stock‑based incentive compensation plans (the Liberty Plans). In February 2014 the Liberty Plans expired pursuant to their terms. Options under these plans had a 10 year life and vested over 5 years. Remaining options under these plans became fully vested with the signing of the Agreement of Merger with Delmar Bancorp in February 2018. In accordance with the terms of the Agreement of Merger between Delmar and Liberty, the Liberty Plan was assumed by Delmar, and the options were converted into and became an option to purchase an adjusted number of shares of the common stock of Delmar at an adjusted exercise price per share. The number of shares was determined by multiplying the number of shares of Liberty common stock for which the option was exercisable by the number of shares of Delmar common stock into which shares of Liberty common stock were convertible in the Merger, which was 0.2857 (the “Conversion Ratio”), rounded to the next lower whole share. The exercise price was determined by dividing the exercise price per share of Liberty common stock by the Conversion Ratio, rounded up to the nearest cent. At the effective time of the merger there were 48,225 options outstanding at an exercise price of $1.18. These shares were converted to 13,771 options outstanding at an exercise price of $4.14.  No options were exercised during the year ended December 31, 2019.  During 2018, 5,062 options were exercised at an exercise price of $4.14. 

Remaining options for 8,709 shares were outstanding as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employees

 

Directors

 

 

 

 

Average

 

 

 

 

 

 

Average

 

 

 

 

    

Shares

    

Price

    

Amount

    

Shares

    

Price

    

Amount

December 31, 2019

 

2,355

 

$

4.14

 

$

9,750

 

6,354

 

$

4.14

 

$

26,306

 

Virginia Partners Stock Option Plan

In 2015 Virginia Partners Bank adopted the 2015 Stock Option Plan (the “2015 Partners Plan”), which allowed both incentive stock options and nonqualified stock options to be granted.  The exercise price of each stock option equaled the market price of Partners' common stock on the date of grant and a stock option’s maximum term was 10 years.  Stock options granted in the years ended December 31, 2018 and 2017 vested over 3 years.  Partners previous stock compensation plan (the “2008 Partners Plan”) provided for the grant of share based awards in the form of incentive stock options and nonqualified stock options to Partners’ directors, officers and employees.  In April 2015 the 2008 Partners Plan was terminated and replaced with the 2015 Partners Plan.  Stock options outstanding prior to April 2015 were granted under the 2008 Partners Plan and became subject to the provisions of the 2015 Partners Plan.  The 2008 Partners Plan also provided for stock options to be granted to seed investors as a reward for the contribution to organizational funds which were at risk if Partners’ organization had not been successful.  Under the 2008 Partners Plan, Partners granted stock options to seed investors in 2008, which were fully vested upon the date of the grant.

As a result of the Share Exchange, each stock option (the "Partners Options"), whether vested or unvested, issued and outstanding immediately prior to the effective time under the 2008 Partners Plan or the 2015 Partners Plan and together with the 2008 Partners Plan, (the "Partners Stock Plans"), immediately 100% vested, to the extent not already vested, and converted into and became stock options to purchase Delmar common stock.  In addition, Delmar assumed each Partners Stock Plan, and assumed each Partners Option in accordance with the terms and conditions of the Partners Stock Plan pursuant to which it was issued.  As such, Partners Options to acquire 149,200 shares of Partner’s common stock at a weighted average exercise price of $10.52 per share were converted into stock options to acquire 256,294 shares of Delmar common stock at a weighed average exercise price of $6.13 per share.  The number of shares was determined by multiplying the number of shares of Partners common stock for which the option was exercisable by the number of shares of Delmar common stock into which shares of Partners common stock were convertible in the Share Exchange, which was 1.7179 (the “Conversion Ratio”), rounded to the next lower whole share. The exercise price was determined by dividing the exercise price per share of Partners common stock by the Conversion Ratio, rounded up to the nearest cent.  

A summary of stock option transactions for 2019 is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2019

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Weighted

 

Average

 

 

 

 

 

 

 

 

 

Average

 

Remaining

 

 

 

 

 

 

 

 

 

Exercise

 

Contractual

 

 

Intrinsic

 

 

 

Shares

 

 

Price

 

Life

 

 

Value

Outstanding at beginning of year

 

 

 —

 

$

 —

 

 

 

 

 

Granted

 

 

256,294

 

 

6.13

 

3.81

 

 

 

Exercised

 

 

(8,589)

 

 

5.83

 

 

 

 

 

Forfeited

 

 

 —

 

 

 —

 

 

 

 

 

Outstanding at end of year

 

 

247,705

 

$

6.14

 

3.81

 

$

485,677

 

 

 

 

 

 

 

 

 

 

 

 

Options exercisable at December 31, 2019

 

 

247,705

 

$

6.14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average fair value of options granted during the year

 

$

1.37

 

 

 

 

 

 

 

 

 

The intrinsic value represents the total pre-tax intrinsic value (the amount by which the current market value of the underlying stock options exceeds the exercise price) that would have been received by the holders had they exercised their stock options on December 31, 2019.

The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

 

 

 

 

 

 

December 31, 2019

 

Dividend yield

 

1.34

%

Expected life

 

1.91

 

Expected volatility

 

4.34

%

Risk-free interest rate

 

1.60

%

 

The expected volatility is based on Delmar’s recent historical volatility.  The risk-free interest rates for periods within the contractual life of the awards are based on the U.S. Treasury yield curve in effect at the time of the grant.  The expected life is based on the contractual life and vesting period for the respective stock option.  The dividend yield assumption is based on Delmar’s expectation of dividend payouts.

As stated in Note 1, the Company follows ASC Topic 718‑10 which requires that stock‑based compensation to employees and directors be recognized as compensation cost in the income statement based on their fair values on the measurement date, which, for the Company, is the date of the grant. All stock option expenses had been fully recognized prior to 2019.